Emerging treatments for postmenopausal osteoporosis – focus on denosumab

Emerging treatments for postmenopausal osteoporosis – focus on denosumab

Piet GeusensDepartment of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands and Biomedical Research Institute, University Hasselt, BelgiumAbstract: The pathway of the receptor activator of the nuclear factor κB ligand (RANKL),...

Full description

Bibliographic Details
Main Author: Piet Geusens
Format: Article
Language:English
Published: Dove Medical Press 2009-06-01
Series:Clinical Interventions in Aging
Subjects:
RANKL OPG Osteoporosis Rheumatoid arthritis Paget's disease of bone Metastatic bone diseases
Online Access:https://www.dovepress.com/emerging-treatments-for-postmenopausal-osteoporosis-ndash-focus-on-den-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/emerging-treatments-for-postmenopausal-osteoporosis-ndash-focus-on-den-peer-reviewed-article-CIA

Similar Items